Ovarian cancer targeted therapy: current landscape and future challenges
Ovarian cancer is one of the deadliest malignancies in women and remains the leading cause of death from gynecological cancers worldwide. The standard treatment typically involves tumor-reducing surgery and cytotoxic chemotherapy; however, many patients are unable to tolerate the side effects of the...
Saved in:
| Main Authors: | Guangli Wang, Hui Yang, Yuling Wang, Juan Qin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1535235/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapy for Recurrent High-Grade Epithelial Ovarian Cancer—The Current Status and Future Trends
by: Vallathol Dilip Harindran, et al.
Published: (2024-04-01) -
Advances and Challenges in Targeted Therapy and Its Combination Strategies for Leukemia
by: Zhiyuan Zhong, et al.
Published: (2025-07-01) -
Targeting the kynurenine pathway: a novel approach in tumour therapy
by: Shuoqi Lin, et al.
Published: (2025-01-01) -
Development of a Patient Decision Aid for Targeted Therapy for Relapsed Ovarian Cancer
by: Hung-Che Chien, et al.
Published: (2025-03-01) -
Progress of targeted FOX family therapy in ovarian cancer
by: Hairong Zhang, et al.
Published: (2025-07-01)